Related Experiment Video
Updated: Jun 24, 2026
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Neoadjuvant lenvatinib for inoperable thyroid cancer: A case report and literature review
Khalid Alshehri1, Yousuf Alqurashi1, Mazin Merdad1
1Department of Otorhinolaryngology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Background:
Poorly differentiated thyroid cancer (PDTC) is now classified as a separate thyroid tumor entity. It has male predominance and poor prognosis compared to differentiated TC.
Case:
We report a case of a patient with PDTC who was previously deemed inoperable. A trial of neoadjuvant lenvatinib therapy was given to the patient after that the tumor become operable and the surgery went successfully.
Conclusions:
Lenvatinib is a feasible option in patients with inoperable TC and can stabilize the lesion size or even reduce it, leading to a more favorable surgical outcome.
